课题基金 / 基金详情

Research of Gene therapy for patients with head and neck carcinomas using CyclinD1

Research of Gene therapy for patients with head and neck carcinomas using CyclinD1
CyclinD1对头颈癌患者的基因治疗研究
批准号:
09671772
负责人:
KUMAZAWA Hirobumi
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

KUMAZAWA Hirobumi的其他基金

相似基金

相关文献

中文摘要
翻译
研究了头颈部鳞状细胞癌患者的生物学恶性程度。本研究通过对头颈部鳞癌中cyclinD1基因扩增和cyclinD1蛋白过表达的研究,探讨cyclinD1基因扩增和cyclinD1蛋白过表达与头颈部鳞癌患者预后的关系。cyclinD1基因的扩增和cyclinD1蛋白的过表达可作为判断头颈部鳞癌生物学恶性程度和预后的参考指标。这些结果为头颈部恶性肿瘤的基因治疗提供了新的思路。
英文摘要
The grading of biological malignancy was studied in patients with head and neck squamous cell carcinomas. The studies concerning the amplification of the cyclinD1 gene and overexpression of cyclinD1 protein in head and neck squamous cell carcinomas were studied to evaluate the prognostic significance of patients. The amplification of cyclinD1 gene and overexpression of cyclinD1 protein in head and neck squamous cell carcinomas were considered to be useful for assessment of biological malignancy and prognosis in head and neck squamous cell carcinomas. These results suggest the approach for genetherapy using cyclinD1 for patients with head and neck carcinomas.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
熊澤博文: "頭頚部癌治療の最前線-悪性度診断-" 癌の臨床. 44・11. 1183-1191 (1998)
Hirofumi Kumazawa:“头颈癌治疗的前沿 - 恶性肿瘤诊断”《癌症临床》44・11(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ryoichi Kyomoto: "Cyclin D1-Gene amplification is amore important prognostic factor than its protein over-expression in human head and ueak carcium" Int.J.Cancer. 74・6. 576-581 (1997)
Ryoichi Kyomoto:“细胞周期蛋白 D1 基因扩增是比人类头部和 ueak 钙中蛋白质过度表达更重要的预后因素”Int.J.Cancer 74・6 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
R.Kyomoto, H.Kumazawa, Y.Toda, N.Sakaida, et al: "CYCLIN-D1-GENE ANPLIFICATION IS A MORE POTENT PROGNOSTIC FACTOR THAN ITS PROTEIN OVER-EXPRESSION IN HUMAN HEAD-AND-NECK SQUAMOUS-CELL CARCINOMA" Int.J.Cancer. 74. 576-581 (1997)
R.Kyomoto、H.Kumazawa、Y.Toda、N.Sakaida 等人:“在人类头颈鳞状细胞癌中,CYCLIN-D1-基因扩增是比蛋白质过度表达更有效的预后因素”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Study for treatment of head and neck cancer by the mechanism of a poptosis
  • 批准号:
    06671742
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.28万
  • 财政年份:
    1994
  • 负责人:
    KUMAZAWA Hirobumi
  • 依托单位:
海外基金